1. Introduction {#sec1-nutrients-11-02075}
===============

Obesogenic diets are associated with a host of chronic diseases. Calorie-dense diets, including those that are high in fat and sucrose, have been shown to blunt insulin sensitivity \[[@B1-nutrients-11-02075],[@B2-nutrients-11-02075]\], increase the risk for cardiovascular disease \[[@B3-nutrients-11-02075],[@B4-nutrients-11-02075]\], and increase the incidence of certain types of cancer \[[@B5-nutrients-11-02075],[@B6-nutrients-11-02075]\]. While consumption of a high-fat (HF) diet is known to produce undesirable outcomes, it has been suggested that maternal diet may play an important role in preventing the negative consequences of poor postnatal diet. For instance, compared to control-fed mice, mice fed an obesogenic diet after weaning had larger adipocytes, higher fasting glucose and insulin levels, and reduced expression of insulin signaling proteins \[[@B7-nutrients-11-02075],[@B8-nutrients-11-02075]\]. However, a maternal low-fat (LF) diet significantly reduced adipocyte size, lowered fasting glucose and insulin, and ameliorated the protein expression changes. Similarly, an obesogenic postnatal diet only resulted in cardiac hypertrophy and elevated fibrosis if it was preceded by an obesogenic prenatal diet, but not if it was preceded by a prenatal LF diet \[[@B9-nutrients-11-02075]\].

It has been hypothesized that perinatal nutrition acts via epigenetic mechanisms to mediate long-term health outcomes. Early life is marked by a highly dynamic epigenetic state. In particular, DNA methylation that is established during gestation is thought to persist into adulthood. Previously, maternal intake of micronutrients such as folate and choline, as well as protein restriction has been associated with altered DNA methylation in adult offspring \[[@B10-nutrients-11-02075],[@B11-nutrients-11-02075],[@B12-nutrients-11-02075]\]. Macronutrient consumption, particularly a HF diet, has been shown to produce methylation differences in energy homeostasis genes, peroxisome proliferator-activated receptor α (*Ppara*) \[[@B13-nutrients-11-02075]\], inflammatory genes, toll-like receptors 1 and 2 (*Tlr1* and *Tlr2*) \[[@B14-nutrients-11-02075]\], and the hepatic cell cycle inhibitor, cyclin-dependent kinase inhibitor (*Cdkn1a*) \[[@B15-nutrients-11-02075]\].

In this experiment, we examined the role of maternal diet on epigenetic programming. Pregnant Sprague-Dawley rats were fed either a HF or a LF diet during gestation and lactation. After weaning, male pups from both groups were fed a HF diet until 12 weeks of age. DNA methylation was measured in hepatic tissue using complementary methylated DNA immunoprecipitation sequencing (MeDIP-seq) and methylation-sensitive restriction enzyme sequencing (MRE-seq). Differentially methylated regions (DMRs) were characterized based on association with CpG islands and genes. Pathway analysis was performed, and gene expression was measured. Finally, we attempted to functionally interpret intergenic DMRs by examining the chromatin structure around each conserved locus.

2. Materials and Methods {#sec2-nutrients-11-02075}
========================

2.1. Animals and Diets {#sec2dot1-nutrients-11-02075}
----------------------

Timed-pregnant Sprague-Dawley rat dams (Charles River Laboratories, Wilmington, MA) were randomized into two groups for dietary treatment during gestation and lactation. The first group of 12 rats received a high-fat diet (HF; Research Diets, Inc.; 45% calories from fat), and the second group of 12 rats received a low-fat diet (LF; AIN93G Research Diets, Inc.; 16% calories from fat). Dams were individually housed with their pups in standard polycarbonate cages in a humidity- and temperature-controlled room on a 12-h light-dark cycle with ad libitum access to food and drinking water \[[@B16-nutrients-11-02075]\]. On postnatal day 21, male offspring (*n* = 10 rats per group from 10 different dams) were all given ad libitum access to only a HF diet until postnatal week 12. Animals were then sacrificed, and the median lobe of the liver was frozen in liquid nitrogen and stored at −70 °C. It has been shown that lobes differ in their capacity to store minerals \[[@B17-nutrients-11-02075]\], susceptibility to certain diseases \[[@B18-nutrients-11-02075]\], and transcriptomic profiles \[[@B19-nutrients-11-02075]\]. In rodents, the left lobe is developmentally distinct from the right, median, and caudate lobes. By selecting the median lobe, not only do we reduce variation between tissue samples, but we also choose a representative region that is developmentally similar to the majority of the liver. Institutional and governmental regulations regarding the ethical use of animals were followed during the study. The protocol for the ethical use of animals was approved by the Institutional Animal Care and Use Committee (IACUC protocol no. 09112).

2.2. Methylated DNA Immunoprecipitation (MeDIP) and Methylation-Sensitive Restriction Enzyme (MRE) Sequencing {#sec2dot2-nutrients-11-02075}
-------------------------------------------------------------------------------------------------------------

Genomic DNA was isolated using previously published methods \[[@B20-nutrients-11-02075]\]. Animals were chosen through an extensive screening process in which gene expression and histology were measured, and the best representatives from each group were used for sequencing. Complementary MeDIP-seq and MRE-seq were then performed using previously published protocols \[[@B20-nutrients-11-02075]\]. Briefly, MeDIP utilizes antibodies against 5-methylcytidine to quantify methylated DNA sequences, while MRE-seq uses restriction enzymes that cut at unmethylated CpG sites. MeDIP-seq provides better coverage and MRE-seq offers superior resolution, so that when combined the methylome can be quantified with high accuracy \[[@B21-nutrients-11-02075],[@B22-nutrients-11-02075]\]. Antibodies, restriction enzymes, DNA fragmentation, and library preparation procedures have been detailed by Li et al. \[[@B23-nutrients-11-02075]\].

2.3. DMR Identification {#sec2dot3-nutrients-11-02075}
-----------------------

MeDIP-seq and MRE-seq data analysis were performed using the methylMnM package in R. A detailed procedure is presented by Zhang et al. \[[@B24-nutrients-11-02075]\]. In brief, the rat genome (Rn4) was partitioned into 500 bp bins, and MeDIP-seq and MRE-seq data were modeled as a function of CpG content, MRE site content, and methylation level within each bin. We used the methylMnM algorithm to test the null hypothesis that methylation level was the same between the two samples. The normalized MeDIP and MRE reads were treated as mutually independent Poisson random variables and their expected values were calculated for each sample within each bin. A test statistic and *p*-value were calculated assuming that the joint distribution of the random variables followed a multinomial distribution. Bins with a Benjamini--Hochberg false discovery rate (FDR) *p*-value \<0.05 were considered significant and were called differentially methylated regions (DMRs). Further information regarding methylMnM can be found on the Bioconductor website: <http://www.bioconductor.org/packages/release/bioc/html/methylMnM.html>) \[[@B23-nutrients-11-02075],[@B24-nutrients-11-02075]\].

2.4. Annotation and Pathway Analysis {#sec2dot4-nutrients-11-02075}
------------------------------------

Next, we examined the association between DMRs and CpG islands. CpG islands were defined based on three criteria: (i) sequence length greater than 200 bp, (ii) GC content greater than 50%, and (iii) an observed-to-expected CpG ratio greater than 0.6. Shores were the 2,000 bp regions upstream and downstream of each island \[[@B25-nutrients-11-02075]\]. We also annotated DMRs based on location relative to genes. DMRs were classified as either intergenic, intragenic, downstream, or in the promoter. Promoter regions were defined as the 1500 bp upstream of the transcription start site (TSS), while downstream regions were defined as the 1500 bp downstream of the transcription end site (TES) \[[@B16-nutrients-11-02075]\]. Intragenic regions included both exonic and intronic sequences of the gene body. Intergenic DMRs fell outside any gene body or 1500 bp flanking region.

Differentially methylated genes (DMGs) were annotated with Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway terms. DAVID Bioinformatics Resources version 6.7 was used to identify enriched annotation clusters and pathways with a high degree of differential methylation (<http://david.abcc.ncifcrf.gov/>) \[[@B26-nutrients-11-02075]\]. Functional clusters were required to have at least 2 GO and/or KEGG Pathway terms, and the majority of terms within each cluster were required to have a Benjamini--Hochberg FDR *p*-value \< 0.05. Similarly, we report KEGG pathways that contained at least 2 DMGs and had a fold enrichment ≥ 1.5 (based on the proportion of a specific pathway's genes that were DMGs).

2.5. Methylation Specific PCR {#sec2dot5-nutrients-11-02075}
-----------------------------

To validate sequencing results, methylation specific PCR (MSP) was used to quantify DNA methylation in all animals. Primer design, genomic DNA isolation, bisulfite conversion, and qPCR were performed using published methods \[[@B20-nutrients-11-02075]\]. The relative amount of methylated DNA was calculated as a ratio using the following equation: % methylated DNA = (quantity of methylated DNA)/(quantity of methylated DNA + quantity of unmethylated DNA) × 100%. All MSP primer information can be found in [Table 1](#nutrients-11-02075-t001){ref-type="table"}.

2.6. Gene Expression {#sec2dot6-nutrients-11-02075}
--------------------

Total RNA was extracted using previously published methods \[[@B20-nutrients-11-02075]\]. Briefly, frozen liver tissue was ground in liquid nitrogen and the Direct-zol™ RNA MiniPrep kit (Zymo Research) was used for RNA isolation. RT-PCR was performed using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) and incubated in a 2720 Thermal Cycler (Applied Biosystems). A serially diluted standard curve was created, and qPCR was carried out using Power SYBR^®^ Green Master Mix (Life Technologies) run in a StepOnePlus™ Real-Time PCR System. All primers were designed using Vector NTI (Life Technologies) and manufactured by Integrated DNA Technologies. Information regarding primers for gene expression is detailed in [Table 2](#nutrients-11-02075-t002){ref-type="table"}.

2.7. Analysis of Intergenic DMRs {#sec2dot7-nutrients-11-02075}
--------------------------------

In previous analyses, DMRs that are not located within close proximity of genes are often ignored. We attempted to uncover functions for these DMRs by using previously published high throughput chromatin contact data (Hi-C) \[[@B27-nutrients-11-02075]\]. Such chromatin contact maps are not publicly available for rat tissue, thus we examined only DMRs that were conserved between species using the phastCons9way track from Genome Browser. Conservation scores range from 0 to 1, where 1 denotes perfect sequence alignment and high conservation. For our analysis, we only considered DMRs that had a mean alignment score \>0.5 over the 500 bp bin.

Next, the analogous region from the Rn4 genome build was identified in the Hg38 genome. We used the 3D Genome Browser to visualize Hi-C data from human liver tissue \[[@B27-nutrients-11-02075],[@B28-nutrients-11-02075]\]. In particular, we examined each of the 500 bp DMRs and the 1 mb region flanking either side of the region. We then located the topologically associated domain (TAD) which contained the DMR. Genes within the TAD were considered to have contact with the nearby DMR. Those genes were selected for gene ontology and pathway analyses.

2.8. Statistical Analysis {#sec2dot8-nutrients-11-02075}
-------------------------

For body weight, food intake, MSP, and gene expression, all pairwise comparisons between groups were made using two-tailed t-tests. For pathway analysis, significant enrichment was determined using the Benjamini--Hochberg FDR *p*-value. All statistical analysis was performed in R (version 3.1.2).

3. Results {#sec3-nutrients-11-02075}
==========

3.1. Offspring Phenotype {#sec3dot1-nutrients-11-02075}
------------------------

Male Sprague-Dawley rats were divided into two groups and exposed to either a LF or a HF diet for seven weeks during gestation and lactation (*n* = 10/group; [Figure 1](#nutrients-11-02075-f001){ref-type="fig"}A). After weaning (postnatal week three), all animals were given a HF dietary challenge that mimicked an obesogenic western diet. Animals were fed the HF diet for nine weeks and sacrificed at 12 weeks of age. Across the nine weeks of post-weaning feeding, there was no difference in food intake between the groups ([Figure 1](#nutrients-11-02075-f001){ref-type="fig"}B). Additionally, body weights were consistent between groups, suggesting that maternal diet was insufficient to compensate for HF-induced postnatal weight gain ([Figure 1](#nutrients-11-02075-f001){ref-type="fig"}C,D).

3.2. DNA Methylation {#sec3dot2-nutrients-11-02075}
--------------------

Despite the lack of phenotypic differences, we hypothesized that epigenetic differences might still exist. Methylated DNA was measured using MeDIP-seq and unmethylated DNA was measured with MRE-seq. Combining the two methods, 1,419 differentially methylated regions (DMRs) were identified between groups ([Figure 2](#nutrients-11-02075-f002){ref-type="fig"}A). Of these, 534 (37.6%) were more highly methylated in the HF group, while 885 (62.4%) were more highly methylated in the LF group ([Figure 2](#nutrients-11-02075-f002){ref-type="fig"}B). Next, analysis of the genomic location of the DMRs revealed that 827 (58.3%) were located in intergenic regions (not within 1,500 bp of a gene), 524 (36.9%) were within the gene body (including intronic and exonic sequences), 48 (3.4%) were in a promoter (within 1,500 bp upstream of the TSS), and 45 (3.2%) were downstream of a gene (within 1500 bp downstream of the TES) ([Figure 2](#nutrients-11-02075-f002){ref-type="fig"}C). We next examined DMR location relative to CpG islands and saw that more than twice as many DMRs were located within CpG shores (*n* = 435, 30.7%) than in islands themselves (*n* = 177, 12.5%, [Figure 2](#nutrients-11-02075-f002){ref-type="fig"}D).

DNA methylation was validated using MSP. First, we tested one DMR located within the *Myh7b* gene that was identified to be more highly methylated in the LF group by MeDIP-seq and MRE-seq ([Figure 3](#nutrients-11-02075-f003){ref-type="fig"}A--D). MSP was performed on six CpG sites within the DMR. Although one site was not differentially methylated, two of the sites were higher but not significantly hypermethylated in the LF group (*p* \< 0.1) and three were significantly more methylated in the LF group (*p* \< 0.05, [Figure 3](#nutrients-11-02075-f003){ref-type="fig"}E). Furthermore, the average DNA methylation across all six sites was significantly higher in the LF group (*p* = 0.0089, [Figure 3](#nutrients-11-02075-f003){ref-type="fig"}F). Negative control was also performed on four CpG sites within the *Gpam* gene ([Figure 3](#nutrients-11-02075-f003){ref-type="fig"}G). Four CpGs that were not computationally identified by MeDIP and MRE analysis were examined with MSP ([Figure 3](#nutrients-11-02075-f003){ref-type="fig"}H,I). Neither the individual sites nor the average over the region showed differential methylation ([Figure 3](#nutrients-11-02075-f003){ref-type="fig"}J,K). Findings here and in our previous work demonstrate the validity of combined MeDIP-seq and MRE-seq analysis \[[@B16-nutrients-11-02075],[@B20-nutrients-11-02075]\].

In order to understand the functional relevance of the gene-associated DMRs, gene ontology (GO) and KEGG pathway analyses were performed. We found that DMGs tended to cluster in processes involved in ion binding, cell morphogenesis, ion channels, and neuronal development ([Table 3](#nutrients-11-02075-t003){ref-type="table"}). Additionally, we found that the biosynthesis of unsaturated fatty acids pathway was most highly enriched for differential methylation, while pathways in cancer contained the greatest number of differentially methylated genes ([Figure 4](#nutrients-11-02075-f004){ref-type="fig"}). Interestingly, we found that other metabolic and cancer pathways were also enriched, including the insulin signaling, colorectal cancer, and mitogen-activated protein kinase (MAPK) signaling pathways.

3.3. Gene Expression {#sec3dot3-nutrients-11-02075}
--------------------

Given the enrichment of differential methylation in cancer and metabolic genes, qPCR was utilized to measure gene expression of 31 differentially methylated genes in those pathways. Details regarding the genomic location and methylation levels of the gene-associated DMRs can be found in [Table 4](#nutrients-11-02075-t004){ref-type="table"}. We found two differentially expressed genes, including *Map3k5* and *Igf1r* (*p* = 0.030 and *p* = 0.026, respectively; [Figure 5](#nutrients-11-02075-f005){ref-type="fig"}). Both *Igf1r* and *Map3k5* were related to cancer and metabolism. Both *Map3k5* and *Igf1r* were more highly expressed in the LF group compared to the HF group.

3.4. Intergenic CpGs {#sec3dot4-nutrients-11-02075}
--------------------

Finally, we attempted to understand the impact of DNA methylation in regions that were not associated with particular genes. The majority of the identified DMRs were located in intergenic regions. Previously, such CpGs have been ignored. We hypothesized that even DMRs without obvious gene contact would impact expression via altering chromatic confirmation. Three-dimensional DNA dynamics have been studied in the human genome using chromatic capture techniques; however, these methods have not been performed in rat samples. Thus, we were only able to address the 42 CpG sites that had a conservation score \>0.5 ([Figure 6](#nutrients-11-02075-f006){ref-type="fig"}A). From the Rn4 genome build, the analogous region was identified in the Hg38 genome. The DMR and the 1 mb region flanking either side were queried for topologically associated domains (TADs) using Hi-C data from liver tissue ([Figure 6](#nutrients-11-02075-f006){ref-type="fig"}B) \[[@B27-nutrients-11-02075]\]. KEGG Pathway and Gene Ontology analyses were performed on all genes that fell within a TAD containing a DMR ([Figure 6](#nutrients-11-02075-f006){ref-type="fig"}C,D). Interestingly, these genes also had functions in metabolism, replicating the findings in the gene-associated DMRs.

We then measured the expression of ten metabolic genes associated with intergenic DMRs ([Figure 7](#nutrients-11-02075-f007){ref-type="fig"}A). We found that *Pik3c3* and *Enox1* were more highly expressed in the HF group (*p* = 0.0028 and *p* = 0.025, respectively) while *Adh5* was more highly expressed in the LF group (*p* = 0.029). We then examined the DMRs within 1 mb of each gene. Two DMRs were located upstream of the *Pik3c3* TSS and were more methylated in the LF group as identified by MeDIP-seq and MRE-seq ([Figure 7](#nutrients-11-02075-f007){ref-type="fig"}A). Four DMRs were located upstream of the *Enox1* TSS. The two more distant DMRs (−889,247 and −888,747 bp upstream) were hypomethylated in the LF group, while the two more proximal DMRs (−472,747 and −373,747 bp upstream) were hypermethylated in the LF group ([Figure 7](#nutrients-11-02075-f007){ref-type="fig"}C). Two DMRs were located upstream of the *Adh5* TSS. MeDIP-seq and MRE-seq showed that the more distant DMR (−391,108 bp upstream) was hypermethylated in the LF group while the more proximal DMR (−170,108 bp upstream) was hypomethylated in the LF group ([Figure 7](#nutrients-11-02075-f007){ref-type="fig"}D).

4. Discussion {#sec4-nutrients-11-02075}
=============

In this study, we investigated the role of maternal diet in hepatic epigenomic programming. Specifically, male Sprague-Dawley rats were fed either a LF or a HF diet during gestation and lactation. After weaning, all animals were given a HF diet challenge. After nine weeks on the post-weaning diet, there was no difference in body weight between groups; however, hepatic DNA methylation was changed at 1419 loci. Closer examination of the DMRs revealed enrichment for metabolic and cancer pathways. Gene expression analysis showed that only *Map3k5* and *Igf1r* were differentially expressed. Finally, we looked at the conserved intergenic DMRs and found that they were also located nearby differentially expressed metabolic genes.

There was no difference in body weight and there were very few changes in gene expression between perinatal LF- and HF-exposed animals. Previous experiments have reported inconsistent results regarding body weight of animals that were given an obesogenic post-weaning diet preceded by different perinatal diets. After 14 weeks on a post-weaning HF diet, mice that had been exposed to a maternal HF diet had higher body weights than those exposed to a maternal LF diet \[[@B29-nutrients-11-02075],[@B30-nutrients-11-02075]\]. Conversely, another study found that maternal dietary fat had no impact on body weight when male mouse offspring were fed a post-weaning HF diet for 17 weeks \[[@B31-nutrients-11-02075]\]. Finally, others have suggested that the impact of maternal diet is time dependent. In Sprague-Dawley rats, it was shown that perinatal diet did not change body weight after eight weeks of post-weaning HF feeding but did produce body weight differences after 16 weeks of post-weaning HF feeding \[[@B32-nutrients-11-02075]\]. In our case, we saw that the perinatal diet was not protective against HF-induced postnatal weight gain after nine weeks of HF feeding. Additionally, our study is limited because we did not consider any other metabolic parameters. Previous work has shown that a prenatal HF diet impacts glucose tolerance, lipid profile, and cardiovascular health \[[@B31-nutrients-11-02075],[@B33-nutrients-11-02075],[@B34-nutrients-11-02075],[@B35-nutrients-11-02075]\]. Such physiological characteristics have also been associated with DNA methylation \[[@B36-nutrients-11-02075],[@B37-nutrients-11-02075],[@B38-nutrients-11-02075]\], so it is possible that the perinatal diet acts through epigenetic mechanisms to affect metabolic outcomes.

The changes in DNA methylation but lack of body weight difference suggest that either perinatally programmed DNA methylation is slowly washed out by a new dietary challenge, or that DNA methylation programming is robust and foreshadows distinct future metabolic outcomes. Given previous findings, we hypothesize that our rats may have been sacrificed before weight differences could be observed. Because metabolic parameters such as resting metabolic rate, macronutrient oxidation, and body composition change during aging \[[@B39-nutrients-11-02075]\], it is possible that younger rats were able to compensate for perinatal perturbations. A similar principle might also explain the small number of differentially expressed genes. Younger animals might be better equipped to combat disturbances in the methylome. Conversely, it may be the case that DNA methylation established during the perinatal period is susceptible to change by post-weaning diet and thus yields no observable difference in the future metabolic outcome. Indeed, exposure to a post-weaning HF diet was shown to mitigate the epigenomic effects of the early-life diet \[[@B31-nutrients-11-02075]\]. Perinatal diet impacted 1,505 DMRs in male offspring given a post-weaning LF, but only 258 DMRs in offspring fed a post-weaning HF diet. We have also highlighted the important role of the post-weaning diet in establishing DNA methylation patterns \[[@B20-nutrients-11-02075]\]. While we previously found that a post-weaning HF diet increased body weight and impacted 3,966 DMRs, we show here that perinatal diet did not alter body weight and only affected 1419 DMRs. This suggests that post-weaning diet is a strong predictor of body weight and perhaps a more powerful determinant of DNA methylation than the perinatal diet. Future investigation should quantify the contributions of gestation, lactation, and post-weaning diet in determining DNA methylation levels in order to understand the dynamic nature of the methylome. Further work should also explore whether epigenetic alterations have the same impact on gene expression and weight gain in older individuals.

Altogether, we measured five differentially expressed genes. Two genes, *Map3k5* and *Igf1r*, contained intragenic DMRs. Previous studies suggested that the two genes respond to metabolic stressors. *Map3k5* is activated by oxidative stress and inflammation \[[@B40-nutrients-11-02075]\], and *Igf1r* participates in insulin signaling and fatty acid uptake \[[@B41-nutrients-11-02075],[@B42-nutrients-11-02075]\]. Moreover, *Map3k5* has been shown to be upregulated in the adipose tissue of obese individuals while *Igf1r* is upregulated in lymphocytes of obese children \[[@B43-nutrients-11-02075],[@B44-nutrients-11-02075]\]. Because a HF diet can induce oxidative stress and inflammation, it is not surprising that we observed lower expression of *Map3k5* in LF-fed animals. Furthermore, the decrease in *Igf1r* expression in the LF group might be attributed to a reduced need for IGF1-mediated fatty acid uptake. Interestingly, expression of both genes was reduced under perinatal LF conditions, but while *Igf1r* had a hypomethylated DMR, *Map3k5* contained a hypermethylated DMR. This might have been due to the position of the DMRs relative to the TSS of each gene. In *Igf1r*, the DMR was located in the first intron, where it could impact transcription in a canonical manner (i.e., increased DNA methylation resulting in decreased gene expression). The DMR associated with *Map3k5* was located much further downstream of the TSS in intron 8. Several studies have suggested that gene body methylation might have non-traditional effects on transcription, which could account for the discrepancy we observed \[[@B45-nutrients-11-02075],[@B46-nutrients-11-02075],[@B47-nutrients-11-02075]\].

Amongst the genes associated with intergenic DMRs, *Adh5*, *Enox1*, and *Pik3c3* were differentially expressed. Given their role in metabolic pathways, it is not surprising that these three genes were differentially expressed as a result of dietary treatments. The reactions catalyzed by *Adh5* and *Enox1* both involve nicotinamine adenine dinucleotide (NAD). The balance between the oxidized and reduced form of the NAD cofactor is important for driving metabolic reactions. *Pik3c3* plays a role in autophagy, which has been shown to be altered by different exposures to a HF diet \[[@B48-nutrients-11-02075],[@B49-nutrients-11-02075],[@B50-nutrients-11-02075]\]. We hypothesize that DNA methylation in more distant areas could be indicative of chromatin state, such that high methylation is correlated with closed chromatin \[[@B51-nutrients-11-02075]\]. This is reflected in the DNA methylation and gene expression patterns that we observed. *Pik3c3* and *Enox1* were expressed at lower levels in the LF group and the proximal DMRs were hypermethylated. Conversely, *Adh5* was highly expressed in the LF group and the proximal DMR was hypomethylated.

This study provides insight into early life nutritional programming; however, limitations should be addressed in further experimentation. Here, we only explored dietary effects in male offspring. In previous studies, we have demonstrated sex-specific physiological and molecular changes after HF diet exposure \[[@B52-nutrients-11-02075],[@B53-nutrients-11-02075],[@B54-nutrients-11-02075]\]. We have also found particularly robust changes in hepatic gene expression and DNA methylation in male rats \[[@B16-nutrients-11-02075],[@B20-nutrients-11-02075],[@B55-nutrients-11-02075],[@B56-nutrients-11-02075]\]. Although this study expands upon our prior findings in males, we cannot assume that these results would broadly apply to females. Further investigation is necessary to test whether diet-induced DNA methylation patterns are observed in both sexes. Another limitation of the current study is that epigenomic profiling was performed on whole liver tissue. While bulk tissue measurements have been previously used to uncover differences in hepatic gene expression and epigenetic profiles \[[@B57-nutrients-11-02075],[@B58-nutrients-11-02075],[@B59-nutrients-11-02075]\], future studies should consider isolating hepatocytes in order to better predict the functional role of differences in DNA methylation.

Our findings represent a novel contribution to the field of nutritional epigenetics. Whereas several other studies have taken gene-targeted approaches to study DNA methylation, we interrogated the entire epigenome to uncover novel differences in DNA methylation. This allowed us to better investigate intergenic DMRs. Previous analysis has focused on gene-associated DMRs located within 1,500 bp upstream and downstream of a gene body. Indeed, certain technologies such as reduced representation bisulfite sequencing are designed to specifically identify DNA methylation differences in regions near gene promoters. Using these methods, the majority of identified DMRs have the advantage of being functionally interpretable. However, intergenic regions are often overlooked. Interestingly, we found intergenic DMRs to account for more than half of all differential methylation. Intergenic DNA methylation is thought to play an important in cellular function and disease. Intergenic DMRs can impact transcription via interaction with enhancer elements \[[@B60-nutrients-11-02075]\], and intergenic demethylation is observed in various cancers \[[@B61-nutrients-11-02075]\]. Currently, there are no bioinformatics approaches to identify specific functions for large numbers of intergenic DMRs. We hypothesized that proximal genes with significant chromatin contact were most likely to be affected by differential methylation. Although this hypothesis was supported by three differentially expressed genes, understanding the role of intergenic methylation should still be a priority in order to facilitate the development of new computational tools to annotate these regions.

5. Conclusions {#sec5-nutrients-11-02075}
==============

Overall, we conclude that perinatal diet impacts hepatic DNA methylation, especially in metabolic and cancer-related pathways. On the other hand, early-life LF diet is not adequate to prevent postnatal weight gain induced by an HF diet. Although minimal, a prenatal LF diet produced changes in gene expression, including increased the expression of *Map3k5*, *Igf1r*, and *Adh5*, and decreased the expression of *Enox1* and *Pik3c3*. Our findings suggest that diet-mediated epigenetic marks established during early life persist despite a HF diet challenge during the postnatal period.
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![Maternal diet did not impact postnatal phenotype when followed by a high-fat (HF) diet. (**A**) Male Sprague-Dawley rats were given either a HF or low-fat (LF) diet during gestation and lactation (seven weeks). Both groups were given a HF diet after weaning (nine weeks; *n* = 10/group). (**B**) Caloric intake after weaning did not differ between the two groups. (**C**) Postnatal, and (**D**) final, body weight did not differ between groups.](nutrients-11-02075-g001){#nutrients-11-02075-f001}

![Maternal diet altered hepatic DNA methylation. (**A**) MeDIP-seq and MRE-seq were performed to quantify genome-wide DNA methylation. (**B**) Sequencing revealed 1,419 differentially methylated regions (DMRs) between groups (false discovery rate, FDR, *p*-value \< 0.05), including 534 (37.6%) that were more highly methylated in the HF group and 885 (62.4%) that were more highly methylated in the LF group. (**C**) DMR position relative to genomic features, including intergenic regions, gene bodies, promoters, and downstream regions. (**D**) DMR location relative to CpG islands and shores.](nutrients-11-02075-g002){#nutrients-11-02075-f002}

![Methylation Specific PCR validates MeDIP-seq and MRE-seq findings. (**A**) Analysis of MeDIP-seq and MRE-seq identified a significant DMR within the gene body of the *Myh7b* gene (FDR *p*-value \< 0.05). (**B**) The DMR spanned exon 17, intron 17/18, exon 18, and part of intron 18/19. (**C**) MeDIP-seq and (**D**) MRE-seq values are given as average reads ± standard error of the mean (SEM). (**E**) MSP was used to measure DNA methylation at six individual CpG sites within the DMR. (**F**) MSP quantities were averaged over the six sites. MSP values are reported as % DNA methylation ± SEM (\* *p* \< 0.05). (**G**) Among regions that were not significantly differentially methylated, four CpGs were chosen in the Gpam gene body as negative controls. (**H**) MeDIP-seq and (**I**) MRE-seq values are given as average reads ± SEM. (**J**) MSP was used to measure DNA methylation at the four CpG sites and (**K**) methylation was averaged over the four sites. MSP values are reported as % DNA methylation ± SEM (\* *p* \< 0.05).](nutrients-11-02075-g003){#nutrients-11-02075-f003}

![Differential methylation was most enriched in metabolic and cancer-related pathways.](nutrients-11-02075-g004){#nutrients-11-02075-f004}

![Gene expression in cancer and metabolism genes. Gene expression values are normalized to the geometric mean of *Actb*, *Gapdh*, and *Rpl7a*. \* *p* \< 0.05.](nutrients-11-02075-g005){#nutrients-11-02075-f005}

![Intergenic DMRs in conserved genomic regions were associated with metabolic genes through chromatin contacts. (**A**) The conservation score was calculated for every intergenic DMR and only those with scores \>0.5 were considered for further analysis (*n* = 42). (**B**) Regions from the Rn4 genome build were aligned with the Hg38 genome and queried for chromatin contacts. As an example, contact maps are shown for the three DMRs with the highest conservation scores. Genes located within the DMR-associated topologically associated domain (TAD; gray bars) were used for functional analysis. (**C**) KEGG Pathway analysis and (**D**) functional clustering showed enrichment for metabolic processes.](nutrients-11-02075-g006){#nutrients-11-02075-f006}

![Expression of metabolic genes associated with intergenic DMRs. (**A**) Three genes were differentially expressed, including *Pik3c3*, *Enox1*, and *Adh5*. DMRs within 1 mb upstream and downstream of the gene body are reported for (**B**) *Pik3c3*, (**C**) *Enox1*, and (**D**) *Adh5*. MeDIP-seq and MRE-seq values are presented as average reads ± SEM.](nutrients-11-02075-g007){#nutrients-11-02075-f007}

nutrients-11-02075-t001_Table 1

###### 

Methylation specific PCR (MSP) primers.

  Gene              CpG Site          Position                              Methylation                          Primers (5′ → 3′)           Efficiency \*
  ----------------- ----------------- ------------------------------------- ------------------------------------ --------------------------- ---------------
  Gpam              CpG 1             Forward +52,479                       U                                    GTAGTGGAATAAGAAGTTTTCGGAG   98.20%
  Reverse +52,587   U                 ACCTTCAAATAACAATCACGCTAC                                                                               
  Forward +52,485   M                 AGAGTAGTAGTGGAATAAGAAGTTTTTGG         99.10%                                                           
  Reverse +52,586   M                 CACCTTCAAATAACAATCACACTAC                                                                              
  CpG 2             Forward +44,337   U                                     GGTGGAGAGGTATTTGTTATGGA              108.20%                     
  Reverse +44,416   U                 CCACACAATCTACAAACTTCACAA                                                                               
  Forward +44,332   M                 TTAGAGGTGGAGAGGTATTTGTTAC             101.19%                                                          
  Reverse +44,414   M                 ACACAATCTACAAACTTCACGAAAA                                                                              
  CpG 3             Forward +7619     U                                     TGTAATTTTTTATTTTAATTTATGTGATTTTTGA   95.56%                      
  Reverse +7736     U                 TTTCTACTTCACAATTACTAATCAACCCA                                                                          
  Forward +7633     M                 TTAATTTACGTGATTTTTGATTGTTATTATTTT     98.50%                                                           
  Reverse +7736     M                 CTACTTCACGATTACTAATCAACCCG                                                                             
  CpG 4             Forward +7288     U                                     AAGTTAAGTTGTAGTGGTTGGGTAATTG         93.47%                      
  Reverse +7360     U                 CCCACTTATTTTAAACAACATCAAACC                                                                            
  Forward +7289     M                 AGTCGTAGTGGTCGGGTAATCG                107.81%                                                          
  Reverse +7357     M                 CCGCTTATTTTAAACAACATCGAA                                                                               
  Myh7b             CpG 1             Forward +9089                         U                                    TGGGTTCGTGTGGGAAATG         99.33%
  Reverse +9181     U                 CCACCTCAACTCTCCCTAAACAA                                                                                
  Forward +9089     M                 CGGGTTCGTGTGGGAAAC                    92.99%                                                           
  Reverse +9181     M                 CCGCCTCAACTCTCCCTAAA                                                                                   
  CpG 2             Forward +9607     U                                     AGGAGTATAAATGGGAGGGTATTGATT          91.86%                      
  Reverse +9757     U                 CATACACAACTTCCAACACCATCC                                                                               
  Forward +9621     M                 CGTGTTGGAGTAGGAGGAGTATAAAC            102.11%                                                          
  Reverse +9753     M                 CGCAACTTCCGACACCATC                                                                                    
  CpG 3             Forward +10,000   U                                     TGATTTGAGGATTATGTGTATTGGATTT         99.04%                      
  Reverse +10,069   U                 CCAATTTCTTTTTCCATTCTCCATAC                                                                             
  Forward +9995     M                 CGAGGATTACGTGTATTGGATTTTAA            103.13%                                                          
  Reverse +10,065   M                 TTTCTTTTTCCATTCTCCGTACAATA                                                                             
  CpG 4             Forward +11,606   U                                     AGGAGTGTATGTTTTTTAAGGTTTTAGATG       96.42%                      
  Reverse +11,701   U                 AACAAAACTACTAAAAATTAAATAACTTCCCA                                                                       
  Forward +11,606   M                 AGGAGTGTATGTTTTTTAAGGTTTTAGACG        98.73%                                                           
  Reverse +11,701   M                 ACGAAACTACTAAAAATTAAATAACTTCCCA                                                                        
  CpG 5             Forward +12,857   U                                     GATTTGGATTTGTTGTTAAGGGTTTT           102.17%                     
  Reverse +12,924   U                 AACCAACACCCACCACTACCTAA                                                                                
  Forward +12,859   M                 TTCGGATTTGTCGTTAAGGGTT                106.16%                                                          
  Reverse 12,927    M                 CCAACACCCACCGCTACC                                                                                     
  CpG 6             Forward +13,120   U                                     TTATTTGGATATGGGATAAGAGAGGG           98.27%                      
  Reverse +13,216   U                 CACCATCTAAAATAATACTACTTTCTTTCACTTAT                                                                    
  Forward +13,120   M                 TTATTTGGATACGGGATAAGAGAGG             102.64%                                                          
  Reverse +13,219   M                 CGTCTAAAATAATACTACTTTCTTTCGCTT                                                                         

\* The qPCR amplification efficiency is calculated based on the slope of the standard curve <https://www.lifetechnologies.com/us/en/home/brands/thermo-scientific/molecular-biology/molecular-biology-learning-center/molecular-biology-resource-library/thermo-scientific-web-tools/qpcr-efficiency-calculator.html>. Slopes between −3.1 and −3.6 giving reaction efficiencies between 90 and 110% are typically acceptable.

nutrients-11-02075-t002_Table 2

###### 

Gene expression primers.

  Gene            Ensembl ID                 Common Name                                               Position        Primers (5′ → 3′)           Efficiency \*
  --------------- -------------------------- --------------------------------------------------------- --------------- --------------------------- ---------------
  Acacb           ENSRNOT00000078868.1       Acetyl-CoA Carboxylase Beta                               Forward +1081   ACCCCAAACTTCCAGAGC          105.70%
  Reverse +1189   TGGGCTACAATGGTGGAG                                                                                                               
  Acox3           ENSRNOT00000049798.3       Acyl-CoA Oxidase 3, Pristanoyl                            Forward +1553   TGACTGGTTGGACTCAGA          94.56%
  Reverse +1629   TCTGATGACTCTCTCGGA                                                                                                               
  Actb            ENSRNOT00000042459.4       Actin Beta                                                Forward +451    GAGACCTTCAACACCCCAGC        104.67%
  Reverse +526    CAGTGGTACGACCAGAGGCA                                                                                                             
  Acvr1c          ENSRNOT00000059280.4       Activin A Receptor Type 1C                                Forward +511    TGATTTATGATGCCACTGCC        100.24%
  Reverse +586    ATTGTCCTTGCGATGGTTCT                                                                                                             
  Adh1            ENSRNOT00000036993.4       Alcohol Dehydrogenase 1                                   Forward +257    ATGAAGGAGTTGGGATAG          100.37%
  Reverse +318    ATCACCTGTTCTTACGCT                                                                                                               
  Adh5            ENSRNOT00000016891.6       Alcohol Dehydrogenase 5                                   Forward +637    GTGTGTCTGATTGGATGTGG        117.98%
  Reverse +700    TGACCTTGGCAGTGTTGA                                                                                                               
  Adh7            ENSRNOT00000015870.4       Alcohol Dehydrogenase 7                                   Forward +262    GAAGCAGTTGGGATTGTGGAGA      108.18%
  Reverse +328    TCACTTTGTCACCTGGTCTCACTG                                                                                                         
  Cacng8          ENSRNOT00000078444.1       Calcium Voltage-Gated Channel Auxiliary Subunit Gamma 8   Forward +297    CTGCGTGAAGATCAACCACT        108.34%
  Reverse +395    ATAGGAAAGATGCTGGAGGC                                                                                                             
  Cpt2            ENSRNOT00000016954.3       Carnitine Palmitoyltransferase 2                          Forward +310    GACACCATGAAGAGATACCT        107.28%
  Reverse +387    ACACAACGCTTCTGTTCT                                                                                                               
  Dapk3           ENSRNOT00000027634.4       Death Associated Protein Kinase 3                         Forward +624    TTCGTCGCCCCTGAGATTGTAA      103.21%
  Reverse +685    ATGACGCCGATGCTCCACATAT                                                                                                           
  Dcc             ENSRNOT00000064947.3       DCC Netrin 1 Receptor                                     Forward +1144   GTGGCTGAAAATGAGGCTGGC       100.76%
  Reverse +1208   ATGGCAGGCTTGGGGACAA                                                                                                              
  Enox1           ENSRNOT00000074868.2       Ecto-NOX Disulfide-Thiol Exchanger 1                      Forward +167    TTGAGAGCATCGCACAGTGT        93.82%
  Reverse +239    ATGCTCCCCAAACCATCA                                                                                                               
  Fads2           ENSRNOT00000059280.4       Fatty Acid Desaturase 2                                   Forward +711    CGTGTTTGTCCTTGGAGAGTGGC     108.89%
  Reverse +790    CATGCTGGTGGTTGTAGGGCA                                                                                                            
  Flnb            ENSRNOT00000066546.1       Filamin B                                                 Forward +353    GCTGGAGAATGTGTCTGT          108.69%
  Reverse +422    ACTGTCAATGGACACGAG                                                                                                               
  Foxo1           ENSRNOT00000018244.5       Forkhead Box O1                                           Forward +994    AGGATAAGGGCGACAGCAACAG      102.12%
  Reverse +1056   GGGACAGATTGTGGCGAATTG                                                                                                            
  Fzd2            ENSRNOT00000032944.2       Frizzled Class Receptor 2                                 Forward +818    TTTTGCCCGTCTCTGGAT          93.13%
  Reverse +889    TAGGTGGTGACCGTGAAGAA                                                                                                             
  Gapdh           ENSRNOT00000050443.4       Glyceraldehyde-3-Phosphate Dehydrogenase                  Forward +220    CTCTACCCACGGCAAGTTCAACG     100.39%
  Reverse +311    CTCGCTCCTGGAAGATGGTGATG                                                                                                          
  Hk3             ENSRNOT00000031935.2       Hexokinase 3                                              Forward +973    CCCTGGTTCCTGGTGCTCAG        119.40%
  Reverse +1050   CCAGCACCAGCCTTACCAGC                                                                                                             
  Igfr1           ENSRNOT00000019267.6       Insulin Like Growth Factor 1 Receptor                     Forward +2239   CTGAGAGGAGGCGGAGAGATG       109.39%
  Reverse +2304   TGTTCCTGCTTCGGCTGG                                                                                                               
  Il1r1           ENSRNOT00000019673.4       Interleukin 1 Receptor Type 1                             Forward +393    GGGTTCATTTGTCTCATTGTGC      101.20%
  Reverse +465    TGACCTCATTTGGATACTCCGT                                                                                                           
  Irs2            ENSRNOT00000032918.6       Insulin Receptor Substrate 2                              Forward +3373   CTTGAAGCGGCTAAGTCT          109.86%
  Reverse +3435   TGGCTGACTTGAAGGAAG                                                                                                               
  Lpin3           ENSRNOT00000022403.5       Lipin 3                                                   Forward +578    CCCTCATCGCAGCCTAAAGACAT     108.38%
  Reverse +657    AGGTCAGCAGATGAAAGGTTGGC                                                                                                          
  Map3k5          ENSRNOT00000051496.6       Mitogen-Activated Protein Kinase Kinase Kinase 5          Forward +455    GTTTTTACAACGCTGACATCGC      105.77%
  Reverse +525    ATGATAAAACAGGGAAGGCTGC                                                                                                           
  Mapk3           ENSRNOT00000087625.1       Mitogen-Activated Protein Kinase 3                        Forward +618    CACTGGCTTTCTTACCGAGT        111.47%
  Reverse +696    GGTGTAGCCCTTGGAGTTAA                                                                                                             
  Mknk2           ENSRNOT00000041106.5       MAP Kinase Interacting Serine/Threonine Kinase 2          Forward +177    TTCAGGGCTTCCACCGTTCG        107.33%
  Reverse +246    TGGGCGGGGTCTAAGGTGAA                                                                                                             
  Msh3            ENSRNOT00000018449.7       MutS Homolog 3                                            Forward +166    TGTCCCCCACAGAACCAGCA        109.37%
  Reverse +229    TTCCCCAGTGACCTCTTCCTGC                                                                                                           
  Mttp            ENSRNOT00000014631.6       Microsomal Triglyceride Transfer Protein                  Forward +1042   TAGAACCTGAGAACCTGTCCAACGC   107.54%
  Reverse +1113   AAGTGCGGAGGTGCTGAATGAAG                                                                                                          
  Ncoa4           ENSRNOT00000066062.3       Nuclear Receptor Coactivator 4                            Forward +611    CCTAGTTCTTCAAGTGTCAGGC      108.75%
  Reverse +686    TGGATGCTGACTTCTGCTCT                                                                                                             
  Nfatc2          ENSRNOT00000065615.1       Nuclear Factor Of Activated T Cells 2                     Forward +1599   GGAGCCAAAGAACAACATGCGGG     100.47%
  Reverse +1674   CAGCTCGATGTCAGCGTTTCGGA                                                                                                          
  Ntrk2           ENSRNOT00000042145.2       Neurotrophic Receptor Tyrosine Kinase 2                   Forward +979    TCCTGGACAAACTCGTCA          99.47%
  Reverse +1058   GGCTTACAAGGCGTTTCT                                                                                                               
  Pik3c3          ENSRNOT00000066816.2       Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3    Forward +60     CTGTGACCTGGACATCAA          93.26%
  Reverse +119    TGTTCTCTCTTCCCTTCC                                                                                                               
  Phkb            ENSRNOT00000049624.4       Phosphorylase Kinase Regulatory Subunit Beta              Forward +369    GCCATAAAGTGTATGAGAGGAG      106.60%
  Reverse +435    TGAACTGCTGGACCTTATCA                                                                                                             
  Ppp1r3b         ENSRNOT00000051720.2       Protein Phosphatase 1 Regulatory Subunit 3B               Forward +838    TATGAAAGAATGGAGTTCGCCGTG    107.84%
  Reverse +909    TTTGCCTTTGTTGCTGTCCCAGTA                                                                                                         
  Rasgrp2         ENSRNOT00000028646.6       RAS Guanyl Releasing Protein 2                            Forward +490    CAAGAAGGAAACCGCAGGCAC       108.06%
  Reverse +565    TCACCTGCCGCTTCCACTTGT                                                                                                            
  Rpl7a           ENSRNOT00000044551.4       Ribosomal Protein L7a                                     Forward +64     GAGGCCAAAAAGGTGGTCAATCC     105.33%
  Reverse +127    CCTGCCCAATGCCGAAGTTCT                                                                                                            
  Runx1t1         ENSRNOT00000066191.1       RUNX1 Translocation Partner 1                             Forward +796    TCCCACTGAGACCTTTTG          109.60%
  Reverse +894    CAGGGTTCTGTTTGGCTA                                                                                                               
  Scd             ENSRNOT00000018447.5       Stearoyl-CoA Desaturase                                   Forward +942    TCAATCTCGGGAGAACATCCTG      109.77%
  Reverse +1013   AAGGCGTGATGGTAGTTGTGGA                                                                                                           
  Scp2            ENSRNOT00000015420.5       Sterol Carrier Protein 2                                  Forward +203    GGCTATGTGTACGGTGAATCCA      105.56%
  Reverse +280    AATGATAGGGATGCCAGTCAGC                                                                                                           
  Skp2            ENSRNOT00000089178.1       S-Phase Kinase Associated Protein 2                       Forward +809    CTGGATTTTCTGAGTCTGCC        100.52%
  Reverse +882    CCAGGAGAGGTTCAGTTCAT                                                                                                             
  Taok3           ENSRNOT00000089043.1       TAO Kinase 3                                              Forward +403    GCTGAAGCACCCGAACACCAT       103.35%
  Reverse +476    ACTCCATCACCAACCAAGCGG                                                                                                            
  Tgfb2           ENSRNOT00000003313.5       Transforming Growth Factor Beta 2                         Forward +1664   ACAATGCTAACTTCTGTGCTGG      91.24%
  Reverse +1735   TGAGGACTTTGGTGTGTTGTGT                                                                                                           
  Traf3           ENSRNOT00000010906.6       TNF Receptor Associated Factor 3                          Forward +870    CTCTTCTGAGGAGTGAGTTGA       108.60%
  Reverse +942    CGCTTAAAACTACAGGTGC                                                                                                              
  Wnt6            ENSRNOT00000023439.6       Wnt Family Member 6                                       Forward +452    GGGGGTTCGAGAATGTCAGTTCC     103.79%
  Reverse +517    GCCTTGCTGTGACTGGAGCAGTT                                                                                                          
  Zbtb16          ENSRNOT00000045356.3       Zinc Finger and BTB Domain Containing 16                  Forward +1695   GCATTTACTGGCTCATTCAG        100.89%
  Reverse +1770   ATCTTCCTTTGAGAACTGGG                                                                                                             

\* The qPCR amplification efficiency is calculated based on the slope of the standard curve <https://www.lifetechnologies.com/us/en/home/brands/thermo-scientific/molecular-biology/molecular-biology-learning-center/molecular-biology-resource-library/thermo-scientific-web-tools/qpcr-efficiency-calculator.html>. Slopes between −3.1 and −3.6 giving reaction efficiencies between 90 and 110% are typically acceptable.

nutrients-11-02075-t003_Table 3

###### 

Gene ontology clustering.

  GO Number                                       GO Annotation                                           Count   Fold Enrichment   FDR *p*-Value
  ----------------------------------------------- ------------------------------------------------------- ------- ----------------- ---------------
  Annotation Cluster 1 (Enrichment Score: 6.24)                                                                                     
  GO:0046872                                      Metal ion binding                                       111     1.54              2.37 × 10^−4^
  GO:0043167                                      Ion binding                                             113     1.52              1.70 × 10^−4^
  GO:0043169                                      Cation binding                                          111     1.52              1.61 × 10^−4^
  Annotation Cluster 2 (Enrichment Score: 5.24)                                                                                     
  GO:0000902                                      Cell morphogenesis                                      26      3.02              0.0013
  GO:0032989                                      Cellular component morphogenesis                        26      2.73              0.0045
  GO:0000904                                      Cell morphogenesis involved in differentiation          20      3.27              0.0046
  Annotation Cluster 3 (Enrichment Score: 4.57)                                                                                     
  GO:0005216                                      Ion channel activity                                    24      2.83              0.0016
  GO:0005261                                      Cation channel activity                                 20      3.18              0.0017
  GO:0022838                                      Substrate specific channel activity                     24      2.75              0.0018
  GO:0015267                                      Channel activity                                        24      2.65              0.0028
  GO:0022803                                      Passive transmembrane transporter activity              24      2.65              0.0028
  GO:0022836                                      Gated channel activity                                  20      2.95              0.0033
  Annotation Cluster 4 (Enrichment Score: 4.18)                                                                                     
  GO:0048667                                      Cell morphogenesis involved in neuron differentiation   19      3.63              0.0029
  GO:0000904                                      Cell morphogenesis involved in differentiation          20      3.27              0.0046
  GO:0007409                                      Axonogenesis                                            17      3.61              0.0056
  GO:0048666                                      Neuron development                                      23      2.62              0.014
  GO:0048812                                      Neuron projection morphogenesis                         17      3.12              0.021
  GO:0031175                                      Neuron projection development                           19      2.75              0.034
  GO:0048858                                      Cell projection morphogenesis                           17      2.82              0.045
  GO:0032990                                      Cell part morphogenesis                                 17      2.71              0.066
  Annotation Cluster 5 (Enrichment Score: 4.08)                                                                                     
  GO:0022836                                      Gated channel activity                                  20      2.95              0.0033
  GO:0005244                                      Voltage-gated ion channel activity                      15      3.47              0.0062
  GO:0022832                                      Voltage-gated channel activity                          15      3.47              0.0062
  Annotation Cluster 6 (Enrichment Score: 3.45)                                                                                     
  GO:0051960                                      Regulation of nervous system development                17      2.95              0.036
  GO:0060284                                      Regulation of cell development                          17      2.87              0.044
  GO:0045664                                      Regulation of neuron differentiation                    14      3.31              0.042
  GO:0050767                                      Regulation of neurogenesis                              15      2.86              0.086

nutrients-11-02075-t004_Table 4

###### 

DMR description.

  Gene      Function            Chromosome   Location               Genomic Feature   HF MeDIP       LF MeDIP        HF MRE         LF MRE          Conservation
  --------- ------------------- ------------ ---------------------- ----------------- -------------- --------------- -------------- --------------- ------------------
  ACVR1C    Cancer              3            40041000--40041500     Intron 3/8        2.33 (0.89)    2.58 (1.02)     1.64 (0)       0               0.0040 (0.016)
  CACNG2    Cancer              7            116000000--116000500   Intron 1/3        8.27 (3.47)    12.26 (4.78)    0.74 (0.42)    0.31 (0.24)     0.77 (0.36)
  CACNG8    Cancer              1            64069000--64069500     Exon 4/4          2.56 (1.15)    2.00 (0.82)     0.27 (0)       6.07 (0)        0.18 (0.34)
  DAPK3     Cancer              7            10009000--10009500     Exon 7/9          12.89 (6.18)   18.09 (10.40)   1.10 (0.68)    0.14 (0)        0.38 (0.45)
  DCC       Cancer              18           69043500--69044000     Intron 1/28       8.56 (3.39)    21.00 (9.64)    3.68 (1.51)    2.16 (1.46)     0.0054 (0.0087)
  FLNB      Cancer              15           19052000--19052500     Intron 1/44       4.89 (2.41)    5.98 (2.59)     2.06 (2.03)    0.51 (0.58)     0.014 (0.017)
  FZD2      Cancer              10           91707500--91708000     Promoter          6.27 (3.41)    1.40 (0.55)     0.27 (0.21)    0.95 (0.71)     0.061 (0.094)
  IGF1R     Cancer              1            122713500--122714000   Intron 1/20       4.31 (1.20)    3.10 (1.81)     0.71 (0)       1.39 (0.99)     0.0057 (0.011)
  IL1R1     Cancer              9            39589500--39590000     Intron 1/10       7.39 (4.28)    4.33 (1.62)     0.12 (0)       1.00 (0.93)     0.0053 (0.0099)
  MAP3K5    Cancer              1            15307000--15307500     Intron 8/12       1.88 (0.83)    4.86 (2.15)     7.37 (0)       1.13 (0)        0.018 (0.050)
  MSH3      Cancer              2            22480500--22481000     Intron 20/23      10.93 (4.44)   4.08 (2.34)     0.42 (0.42)    1.60 (0.93)     0.0050 (0.014)
  NCOA4     Cancer              16           7641000--7641500       Promoter          12.59 (3.16)   5.25 (2.38)     0.27 (0.085)   1.10 (0.84)     0.0026 (0.0036)
  NFATC2    Cancer              3            159682000--159682500   Intron 8/9        10.58 (5.74)   3.06 (1.24)     1.07 (0)       1.73 (2.32)     0.015 (0.0038)
  NTRK2     Cancer              17           11700500--11701500     Intron 12/13      7.81 (3.75)    17.72 (8.57)    4.31 (3.07)    1.21 (1.92)     0.28 (0.41)
  RASGRP2   Cancer              1            209198000--209198500   Intron 15/16      4.29 (2.91)    6.10 (4.07)     0.85 (0.14)    0.19 (0)        0.22 (0.33)
  RUNX1T1   Cancer              5            28230500--28231000     Exon 1/11         2.63 (1.09)    1.00 (0)        1.70 (1.81)    8.70 (11.88)    0.31 (0.43)
  SKP2      Cancer              2            58774500--58775000     Exon 8/10         8.21 (4.43)    17.98 (10.69)   0.93 (1.08)    0               0.13 (0.30)
  TAOK3     Cancer              12           40571000--40571500     Intron 5/19       12.23 (7.54)   7.64 (3.88)     1.51 (2.00)    4.16 (5.87)     0.23 (0.41)
  TGFB2     Cancer              13           102723000--102723500   Intron 6/7        10.45 (6.36)   4.61 (2.68)     0.24 (0)       3.47 (0.13)     0.39 (0.47)
  TRAF3     Cancer              6            135924000--135924500   Promoter          5.27 (2.45)    1.50 (0.71)     0.47 (0.57)    10.45 (21.93)   0.036 (0.073)
  WNT6      Cancer              9            74115500--74117500     Intron 3/3        8.30 (6.35)    15.22 (7.88)    3.40 (4.52)    3.54 (5.89)     0.26 (0.43)
  ZBTB16    Cancer              8            52035000--52036000     Intron 2/6        5.24 (2.69)    7.58 (2.93)     4.00 (0.63)    0.70 (0.30)     0.45 (0.49)
  FOXO1     Cancer/Metabolism   2            141195500--141196000   Intron 1/2        4.84 (2.03)    1.33 (0.58)     0.18 (0.084)   1.31 (0.27)     0.013 (0.026)
  MAPK3     Cancer/Metabolism   1            185936000--185936500   Exon 2/10         7.00 (3.22)    13.88 (6.77)    8.62 (0)       2.72 (0)        0.74 (0.39)
  MKNK2     Cancer/Metabolism   7            10559000--10559500     Exon 14/14        8.85 (3.70)    14.22 (6.72)    3.20 (2.54)    0.98 (0.97)     0.32 (0.42)
  ACACB     Metabolism          12           43424500--43425000     Intron 30/58      4.67 (2.22)    5.63 (2.80)     9.21 (0.59)    3.01 (1.59)     0.0020 (0.0041)
  ACOX3     Metabolism          14           80781000--80781500     Intron 13/19      15.48 (9.69)   3.00 (1.58)     0              0               0.0047 (0.016)
  FADS2     Metabolism          1            212532500--212533000   Intron 4/10       7.83 (3.78)    12.44 (4.55)    1.67 (1.44)    0.87 (0.92)     0.27 (0.44)
  IRS2      Metabolism          16           83384000--83384500     Intron 1/1        9.39 (4.22)    1.67 (0.71)     0.24 (0.17)    2.82 (0.27)     0.00077 (0.0032)
  PHKB      Metabolism          19           22453500--22454000     Intron 13/29      4.43 (2.08)    11.92 (5.76)    0.91 (0.18)    0.19 (0)        0.038 (0.12)
  PPP1R3B   Metabolism          16           60562000--60562500     Intron 1/1        4.08 (2.56)    1.00 (0)        0.49 (0)       6.85 (0)        0.026 (0.076)
  SCD1      Metabolism          1            249463500--249464000   Intron 5/5        10.82 (4.11)   16.68 (5.85)    1.89 (1.58)    0.47 (0.40)     0.012 (0.037)

MeDIP and MRE values are given as average reads (standard deviation). Conservation denotes conservation score (standard deviation).
